HOME
SEARCH
RSS FEED
SUBSCRIBE
Monoclonal Antibody to the Protein NCOA6 (also called ASC-2, AIB-3)
Case ID:
TAB-1160
Web Published:
12/6/2022
Description:
The invention relates to monoclonal antibodies that bind to the transcription factor NCOA6 (ASC-2, AIB-3, TRB, TRAP250, NRC). The antibodies have proven successful reagents for Western blotting and for purifying complexes containing NCOA6. The Western blot experiments revealed that NCOA6 is over-expressed in several breast cancer cell lines, and the purification experiments identified a protein complex containing NCOA6 (the ASCOM complex). The monoclonal antibodies may be useful reagents for studying the role of NCOA6 in transcription and for studying the ASCOM complex.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Patent Status
Direct Link:
https://nih.technologypublisher.com/tech?title=Monoclonal_Antibody_to_the_Pro tein_NCOA6_(also_called_ASC-2%2c_AIB-3)
Category(s):
Collaboration
Licensing
Oncology
Research Materials
Bookmark this page
Download as PDF
For Information, Contact:
Eggerton Campbell
Licensing And Patenting Manager
NIH Technology Transfer
301-402-1648
eggerton.campbell@nih.gov
Inventors:
Paul Meltzer
Keywords:
CC2XXX
CCXXXX
CXXXXX
Home
|
Search
|
RSS
|
Subscribe
© 2024. All Rights Reserved. Powered by
Inteum